Anti-infective vaccination in the 21st century-new horizons for personal and public health

Current Opinion in Microbiology
Ingrid L ScullyAnnaliesa S Anderson

Abstract

The 21st century has seen the licensure of new anti-infective vaccines that have demonstrated their benefit for both individual and population (herd) protection. Despite this there are still many human pathogens for which no vaccine is available. As we learn more about these pathogens, and as technologies advance, more opportunities for vaccine development have become available. This review will address these advances and highlight the paradigm shift from vaccines that are used on a population basis, to others which will have an individual benefit, if successfully licensed, but are not expected to have widespread population based use. The development of the latter vaccines has resulted in a paradigm shift toward vaccinating individuals at specific risk for infection from bacteria such as Staphylococcus aureus or Clostridium difficile, which are members of normal human flora but can cause severe disease under certain circumstances. Increasing levels of antibiotic resistance in such bacteria such as S. aureus have also driven the urgency for the identification of alternative methods of protection that do not rely on treatment or prophylaxis with antibiotics.

References

Jul 11, 2003·Lancet·A MocroftUNKNOWN EuroSIDA study group
Jun 24, 2004·Infection and Immunity·Maurizio ComanducciMariagrazia Pizza
Oct 27, 2005·JAMA : the Journal of the American Medical Association·Catherine A LexauUNKNOWN Active Bacterial Core Surveillance Team
Jan 6, 2006·The New England Journal of Medicine·Guillermo M Ruiz-PalaciosUNKNOWN Human Rotavirus Vaccine Study Group
Jan 6, 2006·The New England Journal of Medicine·Timo VesikariUNKNOWN Rotavirus Efficacy and Safety Trial (REST) Study Team
May 4, 2006·The Journal of Clinical Investigation·Douglas R Lowy, John T Schiller
Sep 19, 2008·The New England Journal of Medicine·K ZamanMark C Steinhoff
Jun 23, 2009·Expert Review of Vaccines·Caroline L Trotter, Martin C J Maiden
Aug 8, 2009·Nucleic Acids Research·Roland SchwarzTobias Müller
Oct 22, 2009·The New England Journal of Medicine·Supachai Rerks-NgarmUNKNOWN MOPH-TAVEG Investigators
Dec 2, 2009·The Journal of Infectious Diseases·Tamara PilishviliUNKNOWN Active Bacterial Core Surveillance/Emerging Infections Program Network
Jan 22, 2010·The New England Journal of Medicine·Israel LowyDonna M Ambrosino
Nov 17, 2010·Nature Reviews. Microbiology·Maria G GuzmanRosanna W Peeling
Dec 18, 2010·Expert Review of Vaccines·E David G McIntosh, Ralf R Reinert
Oct 12, 2011·The Journal of Experimental Medicine·Laszlo KariHarlan D Caldwell
Nov 15, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jessica R MacNeilNancy E Messonnier
May 1, 2013·Microbiology·Robert G K DonaldAnnaliesa S Anderson
Jun 19, 2013·Immunological Reviews·Korey R DemersMichael R Betts
Jan 7, 2014·Seminars in Reproductive Medicine·Harsha SharmaJames H Segars
Mar 13, 2014·Vaccine·David C W MabeyMartin J Holland
Apr 10, 2014·Frontiers in Immunology·Ingrid L ScullyAnnaliesa S Anderson
Jul 30, 2014·Pediatrics·UNKNOWN American Academy of Pediatrics Committee on Infectious Diseases, UNKNOWN American Academy of Pediatrics Bronchiolitis Guidelines Committee

❮ Previous
Next ❯

Citations

Sep 23, 2016·Expert Review of Vaccines·Susanna Esposito, Nicola Principi
Sep 3, 2017·The Journal of Infectious Diseases·Diana LaverdeJohannes Huebner
Nov 16, 2018·International Journal of Molecular Sciences·Antonio PisanoGiuseppe Fiume
Aug 9, 2019·Clinical Medicine Insights. Circulatory, Respiratory and Pulmonary Medicine·Canna J GhiaMark A Fletcher
Jan 13, 2018·Microbiology Spectrum·María Getino, Fernando de la Cruz
Jun 22, 2021·Frontiers in Microbiology·Kevin NeilSébastien Rodrigue

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

© 2021 Meta ULC. All rights reserved